aethlon_8k-030111.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2011
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
(State or other jurisdiction of incorporation)
|
000-21846
(Commission File Number)
|
13-3632859
(I.R.S. Employer Identification No.)
|
|
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
|
|
92122
(Zip Code)
|
Registrant’s telephone number, including area code: (858) 459-7800
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01 Regulation FD Disclosure
The Registrant disclosed that at 9:05 am EST this morning, March 1, 2011, it made a presentation at the Wall Street Analyst Forum 22nd Annual Investor Conference in New York, New York. A copy of the investor presentation materials are being furnished as an exhibit to this report and are incorporated by reference into this Item 7.01. Also, the Registrant posted the investor presentation materials to its website (www.aethlonmedical.com) today, March 1, 2011.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibit is being furnished pursuant to Item 7.01 above.
| |
Exhibit No.
|
|
Description
|
| |
|
|
|
| |
99.1
|
|
Wall Street Analyst Forum Presentation
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AETHLON MEDICAL, INC.
|
| |
(Registrant)
|
| |
|
|
| |
|
|
|
Date: March 1, 2011
|
By:
|
/s/ James B. Frakes
|
| |
|
James B. Frakes
|
| |
|
Chief Financial Officer
|
EXHIBIT INDEX
|
Exhibit No.
|
|
Description
|
| |
|
|
|
99.1
|
|
Investor Presentation Materials
|
4